Sort
23,748 grants matching “melanoma”
NCI National Clinical Trials Network â Network Lead Academic Participating Site
$505,438Lawrence E Flaherty · Wayne State University · UG1 · FY2021 · CA
NCI National Clinical Trials Network â Network Lead Academic Participating Site
$505,438Lawrence E Flaherty · Wayne State University · UG1 · FY2019 · CA
A Convergent Node in Melanoma to Block Multiple Oncogenic Pathways Simultaneously
$505,159Lawrence Kwong · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Fecal Microbiota Transplant and PD-1 blockade in Melanoma
$505,070Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK
$505,021Rona Yaeger · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK
$505,021Rona Yaeger · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK
$505,021Rona Yaeger · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK
$505,021Rona Yaeger · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
The Development of Thermally-activated Metalloenediynes for Cancer Therapy
$505,001Joseph R Dynlacht · Indiana University Indianapolis · R01 · FY2016 · CA
Defining the role of NF1 and SPRED1 loss in melanoma
$504,988Iwei Yeh · University Of California, San Francisco · R37 · FY2020 · CA
Systems Biology of Antigen and T-Cell Transport in Cancer Immunotherapy
$504,978Timothy P Padera · Massachusetts General Hospital · R01 · FY2023 · CA
Novel Strategies for Precision T-cell Therapies
$504,946Steven C. Almo · Albert Einstein College Of Medicine · R01 · FY2019 · CA
DELINEATING GERMLINE, TUMOR AND EXTRINSIC FACTORS DRIVING MUCOSAL MELANOMA RISK AND RESPONSE
$504,910The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2022 · Department of the Army
Melanoma RAS/BRAF Mutation:Heterogeneity-Risk-Prognosis
$504,784Nancy E Thomas · Univ Of North Carolina Chapel Hill · R01 · FY2006 · CA
TRANSLATIONAL CLINICAL TRIALS FOR PRIMARY CNS TUMORS
$504,772David Reardon · Duke University · P50 · FY2011 · NS
Automatic Detection of Critical Dermoscopy Features for Melanoma Diagnosis
$504,760William V Stoecker · Stoecker & Associates · R44 · FY2006 · CA
Elucidating The Adaptive Role Of Serine Codons During Pancreatic Tumorigenesis
$504,559Robert Singhung Banh · New York University School Of Medicine · R37 · FY2024 · CA
Elucidating The Adaptive Role Of Serine Codons During Pancreatic Tumorigenesis
$504,559Robert Singhung Banh · New York University School Of Medicine · R37 · FY2025 · CA
Novel Targeted Combinatorial Therapy for Hepatocellular Carcinoma
$504,528Devanand Sarkar · Virginia Commonwealth University · R01 · FY2021 · CA
The Tumor Microenvironment Niche of Type I conventional Dendritic Cells
$504,511Matthew F Krummel · University Of California, San Francisco · R01 · FY2024 · CA
Renally Excreted Multimodal Core-Shell Silica Nanoparticles as Tumor-Selective Ra
$504,474Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Defining epigenetic regulators of tumor heterogeneity and metastasis in melanoma
$504,361Eva Hernando · New York University School Of Medicine · R01 · FY2023 · CA
Development of a fast scanning, extended field-of-view multiphoton microscope for clinical skin imaging
$504,130Mihaela Balu · University Of California-Irvine · R01 · FY2018 · EB
Role of histotripsy synergized CD40 signaling in the re-engineering of cold tumors
$504,109Ashish Ranjan · Ut Southwestern Medical Center · R01 · FY2025 · CA
Gasdermin E and pyroptosis in cancer
$504,066Judy Lieberman · Boston Children'S Hospital · R01 · FY2020 · CA